Bleakley Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,014
| Closed | -$330K | – | 565 |
|
|
2024
Q4 | $330K | Buy |
+5,014
| New | +$330K | 0.01% | 762 |
|
|
2024
Q3 | – | Sell |
-2,548
| Closed | -$210K | – | 1027 |
|
|
2024
Q2 | $210K | Sell |
2,548
-410
| -14% | -$33.8K | 0.01% | 881 |
|
|
2024
Q1 | $258K | Sell |
2,958
-104
| -3% | -$9.08K | 0.01% | 806 |
|
|
2023
Q4 | $295K | Buy |
3,062
+91
| +3% | +$8.77K | 0.01% | 740 |
|
|
2023
Q3 | $263K | Buy |
2,971
+228
| +8% | +$20.2K | 0.01% | 722 |
|
|
2023
Q2 | $238K | Buy |
2,743
+83
| +3% | +$7.19K | 0.01% | 796 |
|
|
2023
Q1 | $259K | Sell |
2,660
-13,125
| -83% | -$1.28M | 0.01% | 748 |
|
|
2022
Q4 | $1.63M | Buy |
+15,785
| New | +$1.63M | 0.06% | 295 |
|